Early research (Phase 1)Looking for participantsNCT07216066
What this trial is testing
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Who this might be right for
Parkinsons Disease
Regeneron Pharmaceuticals 46